审稿时间:暂无参考数据,审稿时间不确定!
见刊周期:-
温馨提示:以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。
1、投稿方式:在线投稿。
2、刊内网址(202504期):
https://journals.lww.com/jno
3、投稿系统:
https://www.editorialmanager.com/jnutroncol
4、刊内邮箱:jno@nutroncol.org
5、刊内电话:010-63926987;0771-5358436
6、出刊日期:季刊,逢季中月15日出版。
7、官方微信公众号:JNO肿瘤营养学
8、官网信息:不收版面费审稿费。
2026年1月9日星期五
Instruction For Authors
【官网信息】
The
Editorial Office is pleased to answer any questions you may have about
preparing your manuscript in accordance with our guidelines.
Editorial Office contact:
• Contact Email: jno@nutroncol.org
AIMS AND SCOPE
Journal of Nutritional Oncology (JNO) is an international, open-access,
peer-reviewed academic journal that aims to reflect the latest findings
in basic, clinical, and translation research in cancer metabolism,
nutrition, and nutritional intervention. It publishes edge-cutting
scientific studies in the field. It reports recent development and
advances to its audience.
First
launched in 2016, JNO strives to encourage studies and progress in
nutritional oncology, as the role of nutrition in cancer prevention and
treatment draws an increasing spotlight.
The scope of the Journal is but not limited to the following:
-Study on cancer-related metabolism and nutrition
-Basic studies on cancer, including etiology, pathogenesis, pathophysiology, and prevention strategies;
-Prevention, diagnosis, treatment, rehabilitation, and chronic disease management of nutritionally related diseases;
-Studies on public health related to epidemiology, prevention, monitoring, and health policy of nutritionally related diseases;
-Translational science related to nutritional oncology;
-Interdisciplinary research focusing on nutritional oncology.
ONLINE SUBMISSION
First-time Users
Please
click the Register button at
https://www.editorialmanager.com/jnutroncol/default2.aspx. Upon
successful registration, you will be sent an email providing your
username and password. Save this information for future reference.
Note:
If you have received an email from us with an assigned username and
password, or if you are a repeat user, do not register again. Once you
have an assigned username and password, you do not have to re-register.
Authors
click the Login button from the menu at the top of the page and login
to the system as an author. Submit your manuscript according to the
author instructions. You will be able to track the process of your
manuscript through the system.
JOURNAL POLICIES
Duplicate Publication
Manuscripts
are reviewed for possible publication with the understanding that they
are being submitted only to the JNO and have not been published,
simultaneously submitted, or already accepted for publication elsewhere.
The Editorial team may subject any manuscript submitted for
consideration of publication in the JNO to plagiarism-detection
software.
This
does not preclude consideration of a manuscript that has been rejected
by another journal or a complete report that follows publication of
preliminary findings elsewhere, usually in the form of an abstract.
Copies of any possibly duplicate published material should be submitted
with the manuscript under consideration, with a statement in the cover
letter as to why the manuscript currently being submitted is not a
duplicate publication.
Authorship
JNO
expects that each person listed as an author has participated
sufficiently in the intellectual content, the analysis of data, and/or
the writing of the manuscript to take public responsibility for it. Each
author must have reviewed the manuscript, believes it represents valid
work, and approves it for submission.
Moreover,
should the Editorial team request the data upon which the manuscript is
based, the authors shall produce it. Each author's specific
contributions to the work should be indicated; this information will be
published as a footnote to the paper. For example, the areas of
participation might include:
Participated in research design
Participated in the writing or critical revision of the paper
Participated in the performance of the research
Contributed new reagents or analytic tools
Participated in data analysis
An
author may list more than one contribution, and more than one author
may have contributed to the same aspect of the work. Any change in
authorship/contributions after submission must be approved in writing by
all authors and submitted to the Editorial Office for final
consideration.
Plagiarism
As
defined by the World Association of Medical Editors
(http://www.wame.org/resources/publication-ethics-policies-for-medical-journals),
plagiarism is the use of others' published and unpublished ideas or
words (or other intellectual property) without attribution or
permission, and presenting them as new and original rather than derived
from an existing source. The intent and effect of plagiarism is to
mislead the reader as to the contributions of the plagiarizer. This
applies whether the ideas or words are taken from abstracts, research
grant applications, Institutional Review Board applications, or
unpublished or published manuscripts in any publication format (print or
electronic).
is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a
plagiarism screening service that verifies the originality of content
submitted before publication. iThenticate checks submissions against
millions of published research papers, and billions of web content.
Authors, researchers and freelancers can also use iThenticate to screen
their work before submission by visiting http://www.ithenticate.com.
All
allegations of plagiarism are investigated in accordance with the
Committee on Publication Ethics (COPE) guidelines detailed at
https://publicationethics.org/files/u7140/plagiarism%20A.pdf. When
plagiarism is detected at any time before or after publication, the
journal editorial office will take appropriate action as directed by the
standards set forth by COPE. If plagiarism is found, the author, the
author's institution and funding agencies, and the original publication
will be notified. A statement noting the plagiarism, providing a
reference to the plagiarized material, and linking to the original paper
may follow. Depending on the extent of the plagiarism, the paper may
also be formally retracted. For additional information, please visit
http://www.publicationethics.org.
Financial Support and Disclosure of Conflicts
must state all possible conflicts of interest in the manuscript,
including financial, consultant, institutional and other relationships
that might lead to bias or a conflict of interest. If there is no
conflict of interest, this should also be explicitly stated as none
declared. All sources of funding should be acknowledged in the
manuscript.
relevant conflicts of interest and sources of funding should be
included on the title page of the manuscript with the heading "Competing
interests" and “Funding".
For
example: “Competing interests: A has received honoraria from Company Z.
B is currently receiving a grant (#12345) from Organization Y, and is
on the speaker's bureau for Organization X - the CME organizers for
Company A. For the remaining authors none were declared."
“Funding": list all the grant supports/funders for the study.
A
financial disclosure section is part of the submission process and must
be completed by each author at first revision. This information is for
review by the Editors but will be published if relevant to the content
of the accepted manuscript.
primary purpose of the disclosure section is to determine whether
authors have received any commercial financial support that could create
a conflict of interest. In addition to monetary interests, a potential
for conflict of interest can exist whether or not an individual believes
that a relationship (such as dual commitments, competing interests, or
competing loyalties) affects his or her scientific judgment. Please
review ICMJE Uniform Requirements for Manuscripts Submitted to
Biomedical Journals at the following link:
https://www.icmje.org/disclosure-of-interest/.
Ethics
When
reporting studies on human subjects, author should indicate whether the
procedures followed were in accordance with the ethical standards of
the responsible committee on human experimentation (institutional or
regional) and with the Declaration of Helsinki
(https://www.wma.net/policies-post/wma-declaration-of-helsinki/). For
prospective studies involving human participants, authors are expected
to mention about approval of regional/national/institutional or
independent ethics committee or review board, obtaining informed consent
from adult research participants and obtaining assent for children aged
over 7 years participating in the trial. The age beyond which assent
would be required could vary as per regional and/or national guidelines.
Ensure confidentiality of subjects by desisting from mentioning
participants' names, initials or hospital numbers, especially in
illustrative material. When reporting experiments on animals, indicate
whether the institution's or a national research council's guide for, or
any national law on the care and use of laboratory animals was
followed.
Evidence
for approval by a local ethics committee (for both human as well as
animal studies) must be supplied by the authors on demand. Animal
experimental procedures should be as humane as possible, and the details
of anesthetics and analgesics used should be clearly stated. The
ethical standards of experiments must be in accordance with the
guidelines provided by the ARRIVE and World Medical Association
Declaration of Helsinki on Ethical Principles for Medical Research
Involving experimental animals and human beings, respectively. The
journal will not consider any paper which is ethically unacceptable. A
statement on ethics committee permission and ethical practices must be
included in all research articles under the “Methods" section.
We
reserve the right to decline publication of a paper even after it has
been accepted if it becomes apparent that there are serious problems
with the scientific content or violations of our publishing policies.
Studies in Humans and Animals
If
the work involves the use of human subjects, the author should ensure
that the work described has been carried out in accordance with The Code
of Ethics of the World Medical Association (Declaration of Helsinki)
for experiments involving humans. The manuscript should be in line with
the Recommendations for the Conduct, Reporting, Editing and Publication
of Scholarly Work in Medical Journals and aim for the inclusion of
representative human populations (sex, age and ethnicity) as per those
recommendations. The terms sex and gender should be used correctly.
......
https://journals.lww.com/jno/Pages/instructionsforauthors.aspx